Effectiveness of COVID-19 vaccines: findings from real world studies

Description

By the beginning of June 2021, almost 11% of the world’s population had received at least one dose of a coronavirus disease 2019 (COVID‐19) vaccine. This represents an extraordinary scientific and logistic achievement — in 18 months, researchers, manufacturers and governments collaborated to produce and distribute vaccines that appear effective and acceptably safe in preventing COVID‐19 and its complications.

This article reviews findings from the initial real world studies and stresses that researchers in Australia currently do not have timely access to the linked Commonwealth and state datasets needed to perform such analyses.

 

Learning Outcomes

  • Explain key components of the perspective.
  • List main findings.

Authors: David Henry, Mark Jones, Paulina Stehlik and Paul Glasziou

Article Type: Perspective

 

Medical Journal of Australia
N/A
Reading: journal; textbook; book; literature review
1h : 0m
MBA: 1h : 0m
Pharmaceutical Preparations
Medical Practitioner, Medical Student, Doctor-in-Training, Non-Vocationally Registered, Nurse / Midwife, Physiotherapist, Researcher, Retired, Specialist - Other, Specialist General Practitioner
You have to be logged in to see the content of this module.

Provided by

  • © 2024 AMA (WA)
  • doctorportal Learning
  • ABN: 65 630 316 942
  • 14 Stirling Highway, Nedlands WA 6009, Australia
  • PO Box 133, Nedlands WA 6009
  • E: enquiries@dplearning.com.au

doctorportal Learning respectfully acknowledges Aboriginal and Torres Strait Islander peoples as the first inhabitants of Australia. We respect the traditional owners of lands across Australia in which our members and staff work and live, and pay respect to their elders past, present and emerging.